Slideshow

5 Classic Hallucinogens Studied in the Treatment of Addictions

Author(s):

Michael P. Bogenschutz, MD

This slideshow provides information about the compounds, clinically relevant attributes, approximate dose, and data under study.

Related Videos
zoyas222/Adobe Stock
Fedrelina/Adobe Stock
eyetronic/Adobe Stock
Gresel/Adobe Stock
Leo/AdobeStock
Audrey Kuzmin/Adobe Stock
Orawan Pattaramonchai/Adobe Stock
Desemona72/Adobe Stock
2rogan/Adobe Stock
gustavofrazao/Adobe Stock
Related Content
depression
March 5th 2025

BLP-003 for Treatment-Resistant Depression: Phase 2b Patient Enrollment Completed

Leah Kuntz
How to Talk to Teenagers About Substance Use
October 8th 2021

How to Talk to Teenagers About Substance Use

Hannah Simon, MD
cannabis
February 25th 2025

Cannabis Use in Senior Patients

Elizabeth A. Varas, MD
Lloyd Sederer, MD: A Conversation About Addiction and the Opioid Epidemic
March 19th 2021

Lloyd Sederer, MD: A Conversation About Addiction and the Opioid Epidemic

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
addiction
February 12th 2025

Patent Issued for Methods of Identifying Patients With Substance Use-Associated Genetic Markers, Treatment With AD04

Leah Kuntz
alcohol
February 10th 2025

Alcohol: Friend and Foe

John J. Miller, MD
© 2025 MJH Life Sciences

All rights reserved.